GBA1LP and gastric cancer: In the case of GBA, Straniero et al. discovered in 2017 that GBAP1 could act as ceRNA regulating the expression of GBA via miRNA (Straniero et al., 2017) and, more recently, a genetic variation of GBAP1 was associated with gastric cancer risk with over-expression of GBAP1 promoting cell proliferation, invasion, and metastasis (Ma et al., 2019).